Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception

BACKGROUND AND OBJECTIVES: In women with highly active multiple sclerosis (MS), suspending rituximab (RTX) for planning pregnancy is associated with low disease reactivation. Whether this strategy reduces the risk of disease reactivity as compared with suspending natalizumab (NTZ) 3 months after con...

Descripción completa

Detalles Bibliográficos
Autores principales: Demortiere, Sarah, Maarouf, Adil, Rico, Audrey, Boutiere, Clemence, Hilezian, Frederic, Durozard, Pierre, Pelletier, Jean, Audoin, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406425/
https://www.ncbi.nlm.nih.gov/pubmed/37550074
http://dx.doi.org/10.1212/NXI.0000000000200161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406425/
https://www.ncbi.nlm.nih.gov/pubmed/37550074
http://dx.doi.org/10.1212/NXI.0000000000200161

Ejemplares similares